Getting America open again begins with creating confidence and enabling citizens to go back to work and school without fear of contracting COVID. The Back to School Conference: Safely Opening Classrooms in 2021 will be a hybrid (in-person) and virtual conference to demonstrate how this is now possible. On April 13th – 14th thought leaders will assemble in Las Vegas Nevada to build strategies to keep schools open. We will profile successful approaches and showcase advanced technologies and solutions to make schools safe.
Biotech, life sciences, and other high-tech companies often need expensive instruments to conduct research and carry out testing. The problem? They don’t have a use for this equipment all the time, so it often sits idle. If shared properly, this available bandwidth could be used by many different companies, reducing their need to buy the equipment themselves. The obstacle is that companies with available equipment and the companies that need to use that equipment can’t easily connect.
Employers are also starting to use testing for specific assignments. Meenta, for example, recently developed a protocol for a New York law firm that needed to create a bubble-like environment for a weeklong trial that brought together a dozen East Coast lawyers. They took molecular tests before and after the trial and throughout the week received rapid tests administered by a nurse. No one got sick.
Boston-based online platform Meenta Inc. announced the launch of the world’s most comprehensive COVID-19 testing solution. Utilizing the nation’s largest proprietary, digitized network of FDA/EUA-certified labs and testing, Meenta is uniquely positioned to help universities, businesses, agricultural companies, manufacturers, sports, and entertainment organizations seamlessly access these labs, thus eliminating testing supply chain issues and long result wait times.
Boston-based biotech company Meenta recently launched a comprehensive COVID-19 testing solution to create the first complete return-to-work program in the United States. Its proprietary surveillance testing model lets manufacturers and distributors proactively monitor and test a fraction of their staff, resulting in an 80 to 90% savings in testing costs.
Venture Lane also put together a playbook, a 22 page document covering policies ranging from rules for visitors and the guidelines to follow in the event someone tests positive. Members are also offered a free antibody testing by one of Venture Lane’s member company, Meenta.